Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 12—December 2007
Research

Emergence of Methicillin-Resistant Staphylococcus aureus of Animal Origin in Humans

Inge van Loo*1, Xander Huijsdens†1, Edine Tiemersma†, Albert J. de Neeling†, Nienke van de Sande-Bruinsma†, Desiree Beaujean†, Andreas Voss‡, and Jan Kluytmans§¶Comments to Author 
Author affiliations: *Elisabeth Hospital, Tilburg, the Netherlands; †National Institute for Public Health and the Environment, Bilthoven, the Netherlands; ‡Wilhelmina Hospital, Nijmegen, the Netherlands; §Amphia Hospital, Breda, the Netherlands; ¶VUmc Medical Center, Amsterdam, the Netherlands;

Main Article

Table 3

Number and percentage of resistant MRSA isolates for various antimicrobial agents, the Netherlands, February 2007*

Agent Cases, 
no. (%) Controls, 
no. (%) p value
Doxycycline 25 (78) 10 (14) <0.01
Ciprofloxacin 1 (3) 36 (49) <0.01
Tobramycin 4 (13) 25 (34) 0.02
Gentamicin 2 (6) 12(16) 0.14
Clindamycin 12 (38) 15 (20) 0.05
Erythromycin 15 (46) 29 (39) 0.35
Cotrimoxazole 0 7 (10) 0.07
Rifampin 0 6 (8) 0.11
Mupirocin 0 5 (7) 0.15
Vancomycin 0 0

*MRSA, methicillin-resistant Staphylococcus aureus.

Main Article

1These authors contributed equally to this article.

Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external